Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Tianyin Pharmaceutical, Co. reported that it is very...
Sanofi-Aventis announced a 600 million RMB ($90 million)...
Tianyin Pharmaceutical Co. has completed construction of...
ChinaBio® Today profiled Sinoasis Pharmaceuticals,...
Tianyin Pharmaceutical, whose fiscal year ends in two...
Eli Lilly unveiled a new program allowing researchers a...
Tianyin Pharmaceutical Co. received SFDA approvals for...
Cheezheng Tibetan Medicine was approved to IPO on the...
Tianyin Pharmaceutical announced that it currently...
In the ChinaBio® Executive Workshop,...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
